Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on the
hemostats and tissue sealants market provides an in-depth analysis of segments
and sub-segments in the global as well as regional hemostats and tissue
sealants market. The study also highlights the impact of drivers, restraints,
and macro indicators on the global and regional hemostats and tissue sealants
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecasts, and dollar values of the global hemostats
and tissue sealants market. According to the report, the global hemostats and
tissue sealants market is projected to grow at a CAGR of nearly 7% over the
forecast period of 2022-2028.
The global hemostats and tissue sealants market was valued
at over USD 3.7 Billion in 2022 and is expected to reach about USD 5.5 Billion
in 2028, with a CAGR of nearly 7% during the forecast period. Hemostats and
Sealants are the medical devices implemented to prevent hemorrhage and bleeding
caused due to injuries and surgical processes, resulting in progressive
healing. The Coagulation system comprises proteins and blood cells responsible
for blood clots leading to hemostasis, platelet plug formation, etc. The
tremendous growth in the market is expected due to the rising number of
surgeries worldwide. Hemophilia or Immune Thrombocytopenia is a disorder where
the blood doesn’t clot in a typical way. Hemostats and tissue sealants are used
in surgeries to control blood loss. When the blood vessels get damaged, the
mechanisms that prevent blood loss are the blood clot. At the time of surgery,
the bleeding is controlled by a hemostat surgical tool. Tissue sealants are
categorized into two types that are biological substrates and physical agents.
Synthetic agents, collagen-based compounds, fibrin sealants, and tissue
adhesive glues are key types of hemostats and tissue sealants.
COVID-19 was an incomparable global public health emergency
that has affected almost every industry and is projected to impact these
various industry growths during the forecast period. During the Covid-19,
pandemic people were compelled to stay in their homes. The governments of many
countries in the world turned their focus to healthcare from other industries.
This significantly disrupted their supply chain operations and manufacturing as
lockdowns were imposed by the respective governments. Manufacturing facilities
were all shut down due to the pandemic in almost every country across the
globe. Logistical restrictions, manpower shortage, material unavailability, and
other restrictions had reduced the growth of the industry. The pandemic has
affected the normal production of companies. The COVID-19 pandemic has created
instability in the antimicrobial hemostats and tissue sealants market across
the globe. However, the market is now estimated to have reached pre-pandemic
levels and is expected to grow steadily during the forecast period.
The increasing number of surgeries worldwide, a wide range
of applications, patient safety, quick recovery, and technological advancement
are some of the key factors driving the growth of the global hemostats and
tissue sealants market. Moreover, lack of awareness about these devices is a
primary restraining factor in the world hemostats and tissue sealants market.
Medical devices need to go through several examinations before they get
approved thus there are strict regulatory rules to control some of the key
factors restraining the growth of this market. The increasing popularity of MI
procedures, Development of new tissue sealants and hemostats are likely to
bring more opportunities to this market.
The report provides a regional outlook covering geographies
such as North America, Europe, Asia-Pacific, and the Rest of the World. North
America holds command over the global hemostats and tissue sealants market
and is expected to dominate the overall market during the forecast period. The
U.S and Canada are contributor’s major revenue, due to an increase in the
number of outpatient surgical facilities and a surge in the number of MI
surgeries. Furthermore, Europe is the second-largest market for hemostats and
tissue sealants. Germany has dominated the Europe market as the country is
experiencing a considerable rise in the elderly population. Asia Pacific is
expected to grow at the highest CAGR rate over the forecast period due to
increasing investment in the healthcare industry by governments in China and
Japan.
The report on the global Hemostats and tissue sealants
market covers segments such as products. On the basis of product, the
sub-markets include hemostats, tissue sealants and adhesives, and fibrin
sealants.
The report provides profiles of the companies in the market
such as BARD, Becton, Dickinson Company, Baxter International, Inc., Cardinal
Health, Inc., Cohera Medical, Inc., CryoLife, Inc., CSL Behring LLC, Ethicon
US, LLC, HyperBranch Medical Technology, Inc., Integra Lifesciences
Corporation, and Smith & Nephew PLC.
The report provides deep insights into demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the hemostats
and tissue sealants market. Moreover, the study highlights current market
trends and provides forecasts for 2022-2028. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.